Patent · US Active

Transdermal delivery system comprising buprenorphine

US9549903B2 · kind B2 · utility

10Cited by

10References

28Claims

0Family size

Assignee

PURDUE PHARMA L.P. · US

Inventors

Thomas Hille · Neuwied, DE
Gabriel Wauer · Bad Neuenahr-Ahrweiler, DE
Kevin John Smith · Cambridge, GB
Helen Elizabeth Johnson · Cambridge, GB
Gillian Elizabeth Mundin · Cambridge, GB

Key dates

Filing date	Jan 11, 2016
Grant date	Jan 24, 2017
Priority date	—
Expiry date	Jan 11, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to transdermal therapeutic system for the transdermal administration of buprenorphine, comprising a buprenorphine-containing self-adhesive layer structure comprising

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.